risk of cesarean delivery, pre-eclampsia and macrosomia, or large-for-gestational-age infants. 11, 12 In the long term, mothers with GDM are more susceptible to developing type 2 diabetes, 13 whereas their infants are more likely to become overweight or obese later in life. 14 However, such associations from observational studies typically vary with racial disparities. In Canada, for example, the Chinese ethnic group had a lower risk of adverse delivery outcomes than the general Canadian population. 15 Similarly, macrosomic newborns appeared to be more common among Cambodian and Laotian women with GDM when compared to Japanese women with GDM residing in Washington State, United States. 16 The purposes of this study are as follows: (a) to determine the age-standardized incidence of GDM by prepregnancy BMI in Western China to enable comparison with other populations; and (b) to investigate the association between GDM incidence and maternal and neonatal outcomes in Western China, where maternal health is still lagging behind the eastern coast of China. 17 
| METHODS
A multicenter prospective cohort study was conducted in four maternity hospitals in Chengdu, capital of Sichuan Province in Western China. Chengdu is the economic center of Western China, with a gross domestic product of ¥87 693 (approximately US$13 000) per capita and a population of about 14 million in 2016.
18 Details of the study protocol including sampling and data collection procedures have been described previously. 19 Briefly, between
May and August 2015, all pregnant women who attended the hospitals for their antenatal care at 15-20 weeks' gestation were approached and invited to participate in the study. Eligibility criteria were age 18-40 years, singleton fetus, no infertility treatment, and without any severe chronic or infectious diseases. In total, 1901 participants who gave informed consent were recruited and followed up until 12 months postpartum. The study protocol was approved by the human research ethics committees of Curtin University (approval no. HR30/2015) and West China School of Public Health, Sichuan University (approval date 16/3/2015). Between 24 and 28 weeks' gestation, all participants who were not previously diagnosed with diabetes were routinely scheduled for a 75 g, 2-hour oral glucose tolerance test. GDM status was determined according to the International Association of Diabetes and Pregnancy Study Groups criteria, 20 when at least one of the following conditions was met: fasting serum glucose ≥5.1 mmol/L, 1-hour serum glucose ≥10.0 mmol/L, or 2-hour serum glucose ≥8.5 mmol/L.
Maternal and neonatal delivery outcomes were extracted from hospital medical records by two members of the research team. These include gestational age at delivery, mode of delivery (vaginal or cesarean delivery), birthweight and length, Apgar scores at 1 and 5 minutes, and admission to neonatal intensive care unit. Birthweight was classified based on the World Health Organization's definitions, with macrosomia being ≥4000 g and low birthweight <2500 g. Using the birthweight reference percentiles developed for Chinese infants, 21 large for gestational age and small for gestational age were defined as birthweights above the 90th percentile and below the 10th percentile for the corresponding gestational age, respectively. Preterm birth referred to delivery at less than 37 weeks' gestation.
Sociodemographic information, including age, parity, family history of diabetes, education, and income, was obtained from participants during the baseline interview by trained nurses. Prepregnancy weight was also based on selfreport, whereas height was measured using a stadiometer at the interview. According to the recommended categorization for Chinese population, 22 participants with prepregnancy BMI <18.5 kg/m 2 , 18.5-23.9 kg/m 2 , and ≥24 kg/m 2 were classified as underweight, normal, and overweight, respectively. Delivery outcomes and baseline characteristics were compared between women with and without GDM using the Pearson chi-squared tests and two-sample t tests for categorical and continuous variables, respectively. Incidence of GDM with 95% confidence interval (CI) was calculated for each age group (<25, 25-29, and ≥30 years). Age-standardized incidence for the entire sample and for the three prepregnancy BMI categories was then determined using the direct method, with the age distribution of the 2017 world female population as the reference. 23 Linear and logistic regression models were used to assess the association between GDM incidence and maternal and neonatal outcomes. Linear regression models were used for analyzing continuous outcome variables, such as length of hospital stay, gestational age at delivery, birth length, birthweight, and Apgar scores. The corresponding results were reported as beta coefficients with 95% CIs. Logistic regression models were used for analyzing binary outcome variables, including cesarean delivery, preterm delivery, low birthweight, macrosomia, small for gestational age, large for gestational age, and admission to neonatal intensive care unit. Odds ratios (ORs) together with their 95% CI were reported. Both types of models accounted for the effects of confounding factors namely age (continuous), prepregnancy BMI (continuous), family history of diabetes, parity, education level, and annual household income. All statistical analyses were performed in the Stata package version 14.2 (Stata Corp LP, College Station, TX, USA). 
| RESULTS
Of the 1901 participants, women with a history of diabetes before pregnancy (n = 2) and those without confirmation of their GDM status (n = 450) were excluded, resulting in a final sample size of n = 1449 for analysis. No significant difference in age (26.3 vs 26.2 years), prepregnancy BMI (20.8 vs 20.7 kg/m 2 ), family history of diabetes (6.3% vs 6.4%), and parity (30.3% vs 32.5%) between women with GDM confirmation and those without was found. Nonetheless, women without confirmation of GDM status had significantly lower education level and annual household income than did women with GDM confirmation. The respective prevalence of junior secondary education or below and annual household income <¥40 000 were 23.9% and 40.1% in the former, and the corresponding data were 30.2% and 44.9% in the latter (P = 0.011 and 0.044, respectively).
A total of 229 pregnant women (15.8%) were diagnosed with GDM. Women with diabetes were on average older (27.4 ± 4.3 vs 26.1 ± 4.0 years), had higher prepregnancy BMI (21.7 ± 3.1 vs 20.5 ± 2.7 kg/m 2 ), and had higher prevalence of family history of diabetes (10.9% vs 5.4%), when compared with others without the condition (Table 1) . Other characteristics (eg, parity, education level, and annual household income) were not significantly different between the two groups.
We found the GDM incidence increased with advanced maternal age. Among women who were aged <25, 25-29, and ≥30 years, the incidence was 12.6%, 15.7%, and 23.7%, respectively ( Table 2) . A similar upward trend was also evident for the age-standardized incidence in relation to prepregnancy BMI, in which the incidence was 10.8%, 18.4%, and 27.9% among underweight, normal weight, and overweight individuals, respectively ( Table 2) .
Maternal and neonatal outcomes by GDM status are next investigated using univariate (Table 3 ) and multivariate regression analyses (Table 4 ). Compared to women without GDM, those with GDM had a significantly longer length of hospital stay (4.9 ± 1.7 vs 4.4 ± 1.9 days; P = 0.042) and shorter gestational age at delivery (38.6 ± 1.2 vs 39.0 ± 1.1 weeks; P < 0.001).
A higher percentage of women with GDM than without GDM had cesarean deliveries (51.4% compared to 41.5%) (Table 3 ). However, this relationship was no longer statistically significant after adjustment for maternal age, prepregnancy BMI, family history of diabetes, parity, education level, and annual household income during logistic regression modeling (adjusted OR 1.37 [95% CI 0.98-1.91]) (Table  4 ). In addition, babies born to women with GDM were prone to macrosomia (6.2% vs 3.1%), though the elevated risk was not significant after adjustment for confounders (adjusted OR 1.54 [95% CI 0.71-3.37]) (Tables 3 and 4 
| DISCUSSION
The overall GDM incidence was high at 18.3% after age standardization. It increased with maternal age and prepregnancy BMI, which is consistent with the literature. 4 The incidence of GDM in our study is higher than pooled data from a recent systematic review of 25 studies in China (14.8%). 24 However, according to this review, a substantial difference in the incidence rate of GDM across regions of China (from 5.1% to 33.3%) was found. The reason for this wide variation is unclear, but may be because of the differences in the characteristics of participants under study (eg, age, family history of diabetes, physical activity, and dietary habits) and differences in study settings. 24 Similar to our results, another recent study in Qingdao, Eastern China, found that GDM incidence increased with maternal age and BMI. The incidence was 9.7%, 14.8%, and 32.1% among those aged <25, 25-29, and ≥30, respectively, and 6.0%, 17.8%, and 45.7% among those with prepregnancy BMI <18.5, 18.5-23.9, and ≥24, respectively. 25 We also observed that almost 11% of Chinese women with low prepregnancy BMI experienced GDM. A previous large-scale cohort study in Northern California similarly reported a relatively higher age-adjusted prevalence of GDM among Asian women (4.8%) than among non-Hispanic white (3.3%) and Hispanic (3.5%) women at the lowest BMI category of <19 kg/m 2 . 26 This may be attributed to the differences in body fat distribution, as Asian women generally carry more abdominal and visceral fat than Caucasian women at the same age and BMI level, 27 or to early life nutrition and development.
Higher proportions of macrosomia and cesarean delivery were found in the GDM group, similar to previous studies, 28 ,29 although such associations became nonsignificant after adjustment for the effects of confounding factors in the regression models. High blood glucose level of the GDM mothers is associated with neonatal fat deposition and fetal Age-standardized using direct method with reference to the 2017 United Nations world female population. BMI, body mass index; GDM, gestational diabetes mellitus. overgrowth, 20 which may lead to macrosomia and necessitate delivery by cesarean delivery. At the same time, the proportion and risk of small-for-gestational-age newborns were more than double in the GDM group (adjusted OR 2.77 [95% CI 1.45-5.31]), contrary to a recent perinatal cohort study of Chinese women. 30 Our observations indicated a potential link between GDM and both lower and higher rates of growth of the fetus. Diabetic pregnancies complicated by placental vascular change may reduce placental blood flow, leading to fetal growth restriction, 31 especially among women with pre-eclampsia, a common comorbidity of GDM. 32 The strict glycemic control by diabetic pregnant women may also deprive the fetus of nutrition, causing small-for-gestational-age newborns. 33 Furthermore, the significantly longer length of hospital stay incurred by mothers with GDM and the higher incidence of their newborns being admitted to the intensive care unit suggest a possible increase in economic burden as a consequence of their diabetic condition during pregnancy.
T A B L E 2
The present study applied the direct method to calculate the age-standardized incidence. This approach enables the comparison of GDM rates overall and across BMI levels between populations with varying age distributions, which has the advantage over the crude rates derived from specific populations commonly reported in previous studies. One limitation of the study was our reliance on self-reported prepregnancy weight that tends to be underreported. However, it has been shown that a good concordance between self-reported and measured body mass index (approximately 87%) was observed. 34, 35 Another limitation was the lack of confirmation of GDM status for nearly one-quarter (23.7%) of the cohort, as taking the oral glucose tolerance test was not mandatory in Western China, even though it had been prescribed for all participants without a previous diagnosis of diabetes. In addition, participants were recruited from district hospitals, and thus, the results cannot be generalizable to other regions of China. In view of the high incidence of GDM found in the present study, screening for GDM is recommended for Chinese women, regardless of their age, prepregnancy BMI, and demographic characteristics. Moreover, preventive measures and management of the condition during pregnancy should be undertaken given the increased risk of adverse maternal and delivery outcomes among women with GDM. 
